Transforming growth factor β and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 130, Issue 2, 2007, Pages 238-244

  Wolańska, Małgorzata ^a   Bańkowski, Edward ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Extracellular matrix; Human myometrium; PDGF; TGF ; Uterine leiomyoma

Indexed keywords

ACETIC ACID; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TROMETAMOL;

ADULT; ARTICLE; AUTOCRINE EFFECT; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; EXTRACTION; FEMALE; HUMAN; HUMAN TISSUE; INHIBITION KINETICS; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; TISSUE HOMOGENATE; TUMOR GROWTH; UTERUS MYOMA; WESTERN BLOTTING;

EID: 33846244271     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.01.034     Document Type: Article

References (26)

1. Sozen I., and Arici A. Interactions of cytokines, growth factors and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertil Steril 78 (2002) 1-12
2. Arslan A.A., Gold L.I., Mittal K., et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod 20 (2005) 852-863
3. Luo X., Ding L., Xu J., and Chegini N. Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology 146 (2005) 1097-1118
4. Liang M., Wang H., Zhang Y., Lu S., and Wang Z. Expression and functional analysis of platelet-derived growth factor in uterine leiomyomata. Cancer Bio1 Ther 5 (2006) 28-33
5. Taipale J., and Keski-Oja J. Growth factors in the extracellular matrix. FASEB J 11 (1997) 51-59
6. Wolańska M., Sobolewski K., Drożdżewicz M., and Bańkowski E. Extracellular matrix components in uterine leiomyoma and their alteration during the tumour growth. Mol Cell Biochem 189 (1998) 145-152
7. Edmondson S.R., Thumiger S.P., Werther G.A., and Wraight C.J. Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems. Endocr Rev 24 (2003) 737-764
8. Yu C., Wang F., Jin C., et al. Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride - induced hepatic injury and fibrogenesis. Am J Pathol 163 (2003) 1653-1662
9. Shalitin N., Schlesinger H., Levy M.J., Kessler E., and Kessler-Icekson G. Expression of procollagen C-proteinase enhancer in cultured rat heart fibroblasts: evidence for coregulation with type I collagen. J Cell Biochem 90 (2003) 397-407
10. Levens E., Luo X., Ding L., Williams R.S., and Chegini N. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling. Mol Hum Reprod 11 (2005) 489-494
11. Fosang A.J., and Hardingham T.E. Matrix proteoglycans. In: Comper W.D. (Ed). Extracellular matrix vol. 2 (1996), Harwood Academic Publishers, GmbH, Amsterdam 200-229
12. Wolańska M., and Bańkowski E. An accumulation of insulin-like growth factor I (IGF-I) in human myometrium and uterine leiomyomas in various stages of tumour growth. Eur Cytokine Netw 4 (2004) 1-5
13. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
14. Hosenlopp P., Seurin D., Segovia-Quinso B., Hardouin S., and Bionoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154 (1986) 138-143
15. Rosso F., Giorgano A., Barbarisi M., and Barbarisi A. From cell-ECM interactions to tissue engineering. J Cell Physiol 199 (2004) 174-180
16. Schonherr E., and Hausser H.J. Extracellular matrix and cytokines: a functional unit. Dev Immunol 7 (2000) 89-101
17. 1 in human myometrium and leiomyoma. Am J Obstet Gynecol 1 (2003) 76-83
18. Chen L., Klass C., and Woods A. Syndecan-2 regulates transforming growth factor-β signalling. J Biol Chem 279 (2004) 15715-15718
19. Saharinen J., and Keski-Oja J. Specific sequence motif of 8-Cys repeats of TGF-β binding proteins. LTBPs create a hydrophobic interaction surface for binding of small latent TGF-β. Mol Biol Cell 11 (2000) 2691-2704
20. Unso{combining double acute accent}ld C., Hyytiäinen M., Bruckner-Tuderman L., and Keski-Oja J. Latent TGF-β binding protein LTBP-1 contains three potential extracellular matrix interacting domains. J Cell Sci 114 (2001) 187-197
21. Saharinen J., Hyytiäinen M., Taipale J., and Keski-Oja J. Latent TGF-ß binding proteins (LTBPs) - structural extracellular matrix proteins for targeting TGF-ß action. Cytokine Growth Factor Rev 11 (1999) 2691-2704
22. Santra M., Reed C.C., and Iozzo R.V. Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from EGF-binding epitope. J Biol Chem 277 (2002) 35671-35681
23. Vollenhoven B.J., Herrington A.C., and Healy D.L. Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium. J Clin Endocrinol Metab 76 (1993) 1106-1110
24. Battegay E.J., Raines E.W., Seifert R.A., Bowen-Pope D.F., and Ross R. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63 (1990) 515-524
25. Soma Y., and Grotendorst G.R. TGF-beta stimulates primary human skin fibroblast DNA synthesis via autocrine production of PDGF-related peptides. J Cell Physiol 140 (1989) 246-253
26. Di Lieto A., De Falco M., Mansueto G., De Rosa G., Polko F., and Staibano S. Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids: evaluation of the clinical response, the immunohistochemical expression of PDGF, bFG F and VEGF and the vascular pattern. Steroids 70 (2005) 95-102